Africa’s leading pharmaceutical firm, Aspen Pharmacare Holdings Ltd., is set to play a pivotal role in alleviating the supply shortage of the world’s most sought-after obesity medications, according to CEO Stephen Saad.
In an interview, Saad disclosed Aspen’s capacity to bolster the availability of highly demanded medications, including Eli Lilly & Co.’s blockbuster diabetes drug, Mounjaro, across Southern Africa.
Aspen aims to…